Jiwon Oh, MD, PhD, FRCPC - Navigating the High-Efficacy DMT Landscape in MS: Integrating New Data and Real-World Evidence

Visit https://www.peervoice.com/QYN860 to view the entire programme with slides. After completing “Jiwon Oh, MD, PhD, FRCPC - Navigating the High-Efficacy DMT Landscape in MS: Integrating New Data and Real-World Evidence”, participants will be able to: Discuss central nervous system (CNS) penetration of high-efficacy disease-modifying therapies (DMTs) and potential clinical implications; Summarise the benefits and limitations of high-efficacy DMTs and their associated outcomes; Evaluate clinical and real-world data regarding high-efficacy DMTs in the management of people with multiple sclerosis (MS); and Apply evidence-based strategies using high-efficacy DMTs to optimise outcomes in people with MS.